Today, I wrote about BioMarker Strategies: how they got their start and how well they've been doing recently.

I love telling startup stories because it allows me to get close to people's hopes and dreams, and I see the passion that drives them forward each and everyday. (That's one reason I started the "Startup Tuesday" feature here on BaltTech.)

I saw this entrepreneurial spirit in CEO Karen Olson (middle front) and president Scott Allocco (right), when I met with them on Monday. They posed in a photo I took with three other researchers.

It's no small feat that they attracted the attention of Baltimore's Abell Foundation, which made a significant investment in their company recently.  

BioMarker wants to build a faster test for diagnosing cancerous tumors. Their test would take hours instead of weeks, and guide doctors on the best type of drug therapy to use for each patient. Pretty cool stuff.

Do you know a startup that's been doing well lately? Drop a note in the comments below!